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Abstract
Background: NR2E1 (Tlx) is an orphan nuclear receptor that regulates the maintenance and self-renewal of neural
stem cells, and promotes tumourigenesis. Nr2e1-null mice exhibit reduced cortical and limbic structures and
pronounced retinal dystrophy. NR2E1 functions mainly as a repressor of gene transcription in association with the
co-repressors atrophin-1, LSD1, HDAC and BCL11A. Recent evidence suggests that NR2E1 also acts as an activator of
gene transcription. However, co-activator complexes that interact with NR2E1 have not yet been identified. In order
to find potential novel co-regulators for NR2E1, we used a microarray assay for real-time analysis of co-regulator–
nuclear receptor interaction (MARCoNI) that contains peptides representing interaction motifs from potential co-
regulatory proteins, including known co-activator nuclear receptor box sequences (LxxLL motif).
Results: We found that NR2E1 binds strongly to an atrophin-1 peptide (Atro box) used as positive control and to
19 other peptides that constitute candidate NR2E1 partners. Two of these proteins, p300 and androgen receptor
(AR), were further validated by reciprocal pull-down assays. The specificity of NR2E1 binding to peptides in the array
was evaluated using two single amino acid variants, R274G and R276Q, which disrupted the majority of the binding
interactions observed with wild-type NR2E1. The decreased binding affinity of these variants to co-regulators was
further validated by pull-down assays using atrophin1 as bait. Despite the high conservation of arginine 274 in
vertebrates, its reduced interactions with co-regulators were not significant in vivo as determined by retinal
phenotype analysis in single-copy Nr2e1-null mice carrying the variant R274G.
Conclusions: We showed that MARCoNI is a specific assay to test interactions of NR2E1 with candidate co-
regulators. In this way, we unveiled 19 potential co-regulator partners for NR2E1, including eight co-activators. All
the candidates here identified need to be further validated using in vitro and in vivo models. This assay was
sensitive to point mutations in NR2E1 ligand binding domain making it useful to identify mutations and/or small
molecules that alter binding of NR2E1 to protein partners.
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Background
NR2E1 (Tlx) is an orphan nuclear receptor that
regulates neural stem cell maintenance and self-renewal
[1, 2] and promotes tumourigenesis [3, 4]. NR2E1 is cru-
cial for adult stem cell proliferation [5] and plays an im-
portant role in spatial learning through promoting
hippocampal neurogenesis [6]. Nr2e1-null mice are
highly aggressive, have reduced cortical thickness and
limbic structures [7], and display aberrant retinal devel-
opment [8–10]. However, despite increased understand-
ing regarding NR2E1 biological function and its gene
targets [1, 11, 12] over the past few years, its precise mo-
lecular mechanism of action remains poorly understood.
Nuclear receptors interact with multi-protein co-
activator or co-repressor complexes to activate or re-
press transcription, respectively. These co-regulator
complexes have histone modification and chromatin re-
modeling functions that elicit transcriptional control.
Many co-regulators interact with the hydrophobic
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groove of nuclear receptors through specific motifs. Co-
repressors use the consensus amino acid sequence
LxxxIxxxL or co-repressor nuclear receptor (CoRNR) box
motif [13], while co-activators utilize an LxxLL binding
motif, also called the nuclear receptor box [14].
NR2E1 functions mainly as a repressor of gene transcrip-
tion and interacts with the co-repressors atrophin-1 (ATN1)
[12], histone demethylase 1 (LSD1) [15], histone deacety-
lases (HDACs) 3, 5 and 7 [2], and the oncoprotein BCL11A
[16]. In addition, NR2E1 can act as an activator of gene
transcription by binding to the promoters of Wnt7a [1], and
Mash1 [17]. Despite all this knowledge, the composition
and dynamics of the co-repressor complexes formed by
NR2E1 are not well understood and, to date, no co-activator
proteins have been found to interact with NR2E1. The
crystal structure of NR2E1 in complex with a short
sequence from atrophins (Atro box) was recently resolved
showing that the autorepressed conformation of NR2E1
creates a pocket to recruit atrophins, which bind to NR2E1
through an unconventional sequence: ALxxLxxY [18].
To test whether NR2E1 could also bind to co-activators,
we used a microarray assay for real-time analysis of
co-regulator–nuclear receptor interaction (MARCoNI)
[19] containing peptides representing co-regulator
interacting sequences for which the LxxLL motif was
highly enriched. Although many different approaches to
characterize protein-protein interactions have been devel-
oped including far-western, yeast-two-hybrid, electrophor-
etic Mobility Shift Assays (EMSAs), and affinity purification
followed by mass spectrometry, the MARCoNI array has
the advantages of being high-throughput and allowing
for rapid testing of small molecules or mutants that
could affect the interaction of a nuclear receptor with
its protein partners.
We confirmed the specificity of binding of NR2E1 to
peptides in the array by using two single-point variants
in the ligand binding domain: R274G and R276Q. We
also evaluated whether R274G had an overt effect on
retinal development in a mouse model carrying this
variant as a single copy insertion.
Results
To find novel transcriptional co-regulators that interact
with NR2E1, we incubated the N-terminal FLAG-tagged
ligand-binding domain (FLAG-NR2E1LBD) with peptides
of a microarray assay for real-time analysis of co-
regulator–nuclear receptor interaction (MARCoNI) (Pam-
Gene International). This array contained 154 peptides
from 64 co-regulator proteins. Many of these peptides
harbored the LxxLL motif. Since the array did not contain
any previously known direct interactors for NR2E1, we
added a peptide from atrophin-1 as a positive control.
This peptide is referred to as the Atro box and is com-
prised of 16 amino acids that are highly conserved among
atrophins and found to be necessary for the interaction
between NR2E1 and atrophin-1 [20]. Two additional
amino acids on each side were included for stability in the
array (PYADTPALRQLSEYARPHVAFS). Mutations in the
two leucines of the Atro box to alanines (PYADTPAAR
QASEYARPHVAFS) abolish the interaction between
Drosophila Atro and NR2E1 in yeast-two-hybrid assays
[20]. Therefore, we included an Atro box containing these
two leucine to-alanine substitutions as a negative control.
We found that FLAG-NR2E1LBD interacted very strongly
with the Atro-box peptide in the array but bound very
poorly to the mutant Atro box (Fig. 1; p < 0.05, n = 3
arrays). This suggests that the array binding conditions are
permissive for NR2E1 protein:protein interactions, and
therefore appropriate for identifying novel interactions be-
tween NR2E1 and co-regulators.
FLAG-NR2E1LBD also bound to 26 other peptides be-
longing to 19 proteins after applying False Discovery Rate
correction for array size (q < 0.05) and eliminating negative
fluorescence values (Additional file 1: Table S1 and Fig. 2).
These interactions were; however, weaker than the inter-
action with atrophin-1 (Fig. 1) and may represent indirect
interactions. Importantly, none of these proteins have previ-
ously been shown to directly or indirectly bind to NR2E1.
Some of the peptides that interacted with FLAG-NR2ELBD
in the array are cofactors known to function primarily in co-
activator complexes. These include the SRC family members
NCOA1 (SRC-1), NCOA2 (SRC-2) and NCOA3 (SRC-3)
[21]; the ATP-dependent chromatin remodeling protein,
Fig. 1 MARCoNI array validated with Atro box. Cell lysates from HEK293
cells expressing wild-type FLAG-NR2E1LBD or variant FLAG-NR2E1LBD
(R274G or R276Q) protein truncations were prepared. Vehicle-treated cells
were also included. These lysates were tested in the MARCoNI array,
which contained a wild-type (PYADTPALRQLSEYARPHVAFS) and mutant
(PYADTPAARQASEYARPHVAFS) Atro box as positive and negative
controls, respectively. FLAG-NR2E1LBD interacted strongly with the
wild-type Atro box and with significantly reduced affinity to the mutant
Atro box. The FLAG-NR2E1LDB variants did not bind to either of the ATRO
peptides. AU, arbitrary units; LBD, ligand binding domain; *, significantly
different from wild-type (p< 0.01). n= 3
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Chromodomain Helicase DNA Binding Protein 9 (CHD9)
[22]; Proline-Rich Nuclear Receptor Coactivator (PNRC1)
[23]; Peroxisome Proliferator-Activated Receptor Gamma,
Coactivator-Related (PPRC1) [24]; the scaffold Transform-
ation/Transcription Domain-Associated Protein (TRRAP)
[25] and the histone acetyltransferase P300 [26] (Fig. 2).
Other proteins that showed significant binding to FLAG-
NR2ELBD in the array are known to be primarily part of co-
repressor complexes. These include the cell-cycle check-
point protein human homolog of RAD9 [27]; the NR2E3
co-repressor and RNA helicase DHX30 (RetCoR) [28]; the
HDAC-associated protein NCOR2 (SMRT) [29]; and Nu-
clear Receptor Interacting Protein 1 (NRIP1; RIP140) [30].
Interestingly, we found that six out of 14 NRIP1-derived
peptides representing different motifs in the array showed
significant interaction with FLAG-NR2ELBD (Fig. 2).
We also observed that other co-regulators that can act as
either co-activators or co-repressors are also targets in the
array. These proteins are Proline, Glutamate and Leucine
Rich Protein 1 (PELP1) [31]; the Histone methyltransferase
Nuclear Receptor Binding SET Domain Protein 1 (NSD1)
[32], and Tripartite Motif Containing 24 (TIF1A) [33] (Fig. 2).
In addition, transcription factors such as Prospero
Homeobox 1 (PROX1) and androgen receptor (AR) also
interacted with FLAG-NR2ELBD in the array (Fig. 2).
PROX1 functions as a co-regulator through LxxLL mo-
tifs [34] and AR harbors LxxLL-like motifs [35].
Other proteins that are sufficient to inhibit transcription
factors were also candidate partners for NR2E1. These in-
clude P21 Protein (Cdc42/Rac)-Activated Kinase 6 (PAK6),
which phosphorylates AR and inhibits its transcriptional ac-
tivity [36]; and Nuclear Factor of Kappa Light Polypeptide
Gene Enhancer in B-Cells (IKBB), that inhibits NF-kappa-B
by sequestering it in the cytoplasm [37] (Fig. 2).
To further assess the specificity of the array, we devel-
oped two FLAG-NR2E1 variants, each harboring a single-
point variant in the LBD of NR2E1: an arginine-to-glycine
substitution in codon 274 (R274G) and an arginine-to-
glutamine substitution in codon 276 (R276Q). The LBD of
NR2E1 is highly conserved in vertebrates (Fig. 3), so we hy-
pothesized that amino-acid changes in the LBD will affect
the ability of NR2E1 to interact with its protein partners.
We previously identified an amino-acid change of unknown
significance in arginine 274-to-glycine in the human
Fig. 2 Twenty six novel co-regulator interacting peptides identified as binding to NR2E1 LBD in the MARCoNI array. Cell lysates from HEK293 cells expressing
wild-type FLAG-NR2E1LBD or variant FLAG-NR2E1LBD (R274G or R276Q) protein truncations were prepared. Vehicle-treated cells were also included. These
lysates were tested in the MARCoNI array, which contained 154 peptides from 64 co-regulator proteins. Only the significant FLAG-NR2E1LBD binding interac-
tions with 26 co-regulators (q< 0.05) are depicted in the histogram. The NR2E1LBD variants abolished the majority of binding interactions observed between
wild-type NR2E1LBD and co-regulator peptides. However, triangles indicate peptides that did not interact significantly differently with NR2E1LBD wild-type and
the variant(s) (q> 0.05). AU, arbitrary units; LBD, ligand binding domain; peptide ID: co-regulator UniProt ID_amino acid start_amino acid end
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population (mother and son) in the heterozygous state [38].
This arginine is highly conserved not only within NR2E1
but also within its close relative NR2E3. Furthermore,
amino-acid similarity is also found in other nuclear recep-
tors of the same family such as NR2F2 where there is a ly-
sine instead of an arginine in aligned regions of the ligand
binding domain corresponding to NR2E1 codon 274
(Fig. 3). This conservation suggests that an amino-acid with
a positively-charged side chain in this region is important
for normal protein function. Furthermore, arginine 274 cor-
responds to arginine 309 in NR2E3 and its substitution to
glycine in NR2E3 affects photoreceptor development in
humans [39, 40]. Interestingly, we observed that both vari-
ants caused a reduction in the binding of NR2E1 to the
Atro box and the majority of the peptide interactions found
in the array (17/26 peptides). The exceptions were peptides
belonging to PELP1, IKBB, CDH9 and NRIP1 which did
not show a significant reduction in interaction with FLAG-
NR2E1LBD R274G and R276Q, and also PAK6 and NCOA3,
which showed comparable binding to FLAG-NR2E1LBD
R276Q and wild-type NR2E1, but reduced binding to
FLAG-NR2E1LBD R274G (Fig. 2).
We further studied the ability of FLAG-NR2E1LBD
R274G or R276Q to interact with human atrophin-1 by
affinity purification assays. We used bacterially expressed
atrophin-1-GST (846–1191) containing the Atro box as
a bait and incubated it with HEK293 lysates containing
the wild-type and variant FLAG-NR2E1LBD proteins
used in the peptide array. In agreement with what we
observed in the array, there was decreased binding of
both R274G and R276Q to atrophin-1 suggesting that
these amino acid changes alter the conformation of
NR2E1 and its capacity to interact with its protein part-
ners (Additional file 2: Table S2 and Fig. 4).
We selected two proteins, AR and P300, from the
array for further analysis. AR is a nuclear hormone
receptor of the NR3C class. We chose AR because in
addition to its well-known role in cancer and male re-
productive function, it also has a role in neurogenesis
[41–43]. The array included the FxxLF motif of AR, lo-
cated in its NH2-terminal region. This motif interacts
with AR itself to stabilize the ligand-bound AR complex
by interacting with different regions of the AR ligand
binding domain [35]. The FxxLF motif also mediates AR
interaction with co-regulators such as Melanoma Anti-
gen Gene Protein-A11 (MAGE-11) [44]. P300 is an ace-
tyltransferase that acetylates histones and other proteins.
P300 also acts as a scaffold for transcription factors and
other components of the basal transcription machinery
to facilitate chromatin remodeling and gene transcrip-
tion [26]. We chose P300 because it is a co-activator that
has well-established roles in regulating neural stem cell
differentiation [45, 46]. We observed that AR and P300
precipitated with NR2E1 in reciprocal pull-downs
(Fig. 5). Importantly, we also verified the lack of binding
of PRGC1 in the MARCoNI array by pull-down experi-
ments (Fig. 5).
Since the NR2E1 variants used in this study have a
dramatic effect on the ability of NR2E1 to interact with
its partners, we studied the effects of R274G during reti-
nogenesis in vivo. We utilized the eye due to its salient
and robust phenotype in Nr2e1-null (Nr2e1frc/frc) mice of
retinal disorganization and abnormal blood vessels, as
well as for the feasibility of studying eye defects. We
have previously shown that a wild-type copy of human
NR2E1 can rescue the Nr2e1-null phenotype in the eye
[47]. We analyzed the retinal blood vessel numbers and
retinal thickness of a transgenic mouse harboring the
R274G mutation as a single-copy on the X-Chromosome
[48]. We compared littermates that were wild-type,
Nr2e1frc/+ or Nr2e1frc/frc, with or without the single-copy
Hprt knock-in R274G variant. In this way, we could
Fig. 3 Arginines 274 and 276 are highly conserved in NR2E1. UCSC genome browser (https://genome.ucsc.edu/) image depicting NR2E1, and the
conservation region of the two most related nuclear receptor binding domains; NR2E3 and NR2F2. A positively charged amino acid is conserved
at positions 274 and 276. NR2E1 shows complete identity of arginine 274 and 276 from humans to zebrafish (red rectangles). In NR2E3, 274 is
similarly conserved, but 276 becomes lysine in distant species. In NR2F2 a lysine, instead of arginine, is similarly conserved at both positions
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study possible gain of function, dominant negative or
loss of function behavior of R274G. Strikingly, we found
that the variant R274G did not affect blood vessel or
radial symmetry (Fig. 6a and b). Similarly, the reduced
retinal thickness of Nr2e1frc/frc mice was not observed in
mice harboring the R274G variant on any of the Nr2e1
backgrounds studied (Fig. 6c and d), suggesting the
ability to functionally act as wild-type. In conclusion,
R274G does not generate an overt retinal phenotype
suggesting that there are compensatory mechanisms that
rescue the reduced NR2E1 binding observed in vitro.
Discussion
In this study, we used a peptide array to find novel
interactors for NR2E1 that revealed 19 candidate co-
regulator proteins. We also found two single amino-acid
variants of NR2E1 that disrupted its binding to most
co-regulators and that one of them, R274G, did not have
an overt physiological significance in the retina. Our re-
sults identify putative co-regulators that can interact
with NR2E1.
Proteins interact through domains, many of which
bind to short peptide sequences [49]. Although the
peptides in the array represent some of these short linear
sequences, they lack the context of the full protein and
thus may participate in non-specific interactions. To
evaluate the specificity of the array and the appropriate-
ness of this approach, we used as a positive control the
Atro box, and as a negative internal control the mutated
Atro box. We also used the FLAG-NR2E1LBD single
amino-acid variants R274G and R276Q as experimental
negative controls. We observed strong binding of
NR2E1 to the wild-type Atro box and decreased binding
to the mutated Atro box. Furthermore, we observed that
FLAG-NR2E1LBD R274G and R276Q failed to interact
with most of the NR2E1 putative interactors in the array
suggesting that these variants generated a conform-
ational change in NR2E1 that prevented its binding to
other proteins. This hypothesis was further strengthened
in pull-down assays using atrophin-1 as bait where both
NR2E1 variants interacted with atrophin-1 with much
less affinity than with wild-type. Together, these data
suggest that the binding of NR2E1 to the interactors in
the array was specific.
Importantly, we noted that the binding of NR2E1 to
other peptides in the array was weaker than the binding
Fig. 4 NR2E1 variants R274G and R276G exhibited decreased binding to atrophin-1. GST, or GST-Atrophin-1846–1191 containing the Atro box, were
over-expressed in E.coli and incubated with HEK293 cell lysate containing either FLAG-NR2E1LBD, FLAG-NR2E1LBD R274G, or FLAG-NR2E1LBD R276Q.
After incubation with glutathione/sepharose beads, purified complexes were resolved by SDS-PAGE followed by western blot using an anti-FLAG
antibody. a Note the decreased binding of the FLAG-NR2E1LBD R274G and R276Q variants to GST-Arophin-1846–1191. b Western blot quantification
of three independent experiments. The signal intensity detected with anti-FLAG antibody for each pull down was normalized to the input signal.
Note that wild-type NR2E1 binds eight times more to atrophin-1 compared to R274G. Error bars, standard error of the mean; GST, glutathione-S-
transferase; LBD, ligand binding domain FLAG. n = 3
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observed for atrophin-1, a known direct NR2E1 interac-
tor. This could be due to the fact that the interaction of
NR2E1 to the other peptides in the array is more transi-
ent or indirect.
Our results then suggest that NR2E1 uses different co-
regulator complexes to affect neural precursor behavior.
For example, mouse Prox1, an interactor of NR2E1 in
the array, has a role in controlling the balance between
neural progenitor self-renewal and neuronal differenti-
ation by inhibiting Notch1 expression [50]. Interestingly,
the expression of the Prox1 homolog in Drosophila,
prospero, is regulated by the homolog of NR2E1, Tlx
[51], suggesting a role for NR2E1 in controlling PROX1
biological output. Another interactor in the array that is
also a neural precursor-related protein is DHX30
(RetCoR), which is important for mediating NR2E3 re-
pressor function in retinal progenitor cells [28].
An intriguing co-repressor target is NRIP1 that had 14
motifs in the array, out of which six interacted with
NR2E1. NRIP1 is expressed in the brain including the
neurogenic region of the dentate gyrus [52], but its role
in neurogenesis, if any, is unknown and worth exploring.
Interestingly, three co-activators members of the SRC
family (SRC-1, SRC-2 and SRC-3) were found to interact
with NR2E1 in the array. Although it is unknown
whether they have a role in neural stem cell behavior,
there is some evidence that SRC-1 could be involved in
neurogenesis as it is upregulated during neuronal differ-
entiation in vitro [53].
Two important scaffolds of multi-protein co-activator
complexes, TRRAP and P300, also interacted with
NR2E1 in the array. TRRAP is found mutated in patients
with schizophrenia [54] and controls the tumourigenicity
of brain tumour initiating cells which resemble neural
stem cells [55]. In the brain, P300 mediates the induc-
tion of the astrocyte lineage [46] and works with the
transcription factor Zfp521 to directly activate early
neural genes [45]. Understanding the biological import-
ance of the interaction of these adaptor proteins with
NR2E1 would greatly advance our knowledge of NR2E1
mechanisms of action.
Many nuclear receptors have been shown to cooperate
to regulate gene transcription. It is an interesting possi-
bility that AR and NR2E1 could function in a complex
to synergistically regulate adult neurogenesis where
testosterone plays a role [42, 43]. In addition, this
interaction could be important during the development
of prostate cancer where NR2E1 has been shown to have
an oncogenic function [4].
Importantly, we successfully pulled-down P300 and
AR with GST-NR2E1, thus reproducing by an orthog-
onal experiment the results from the array. This strongly
suggests that the array is a reliable tool to identify novel
nuclear receptor interactors.
Intriguingly, the variant R274G did not have an effect
on retinal development in vivo. Since we observed
decreased binding of R274G to atrophin-1 in two
orthogonal approaches, we suggest that NR2E1 protein
conformation was indeed compromised by this arginine-
to-glycine substitution. It is possible that the interactions
detected in this study are not functional during gross
retinal development or that there may have been a
compensatory mechanism such as upregulation of
NR2E1 or some of its co-regulators to compensate for
the lower affinity of NR2E1 towards its protein partners.
Fig. 5 NR2E1 interacted with P300 and androgen receptor. GST, or
GST-NR2E1LBD were over-expressed in E.coli and incubated with HEK293
cell lysate containing different overexpressed proteins: (a) Myc-tagged
P300 (P300-Myc), EGFP-tagged androgen receptor (AR-EGFP) and
myc-tagged PRGC1 (Myc-PRGC1). After incubation with glutathione/
sepharose beads, purified complexes were resolved by SDS-PAGE
followed by western blot using anti-EGFP, and anti-myc antibodies. Note
that P300 and AR do not bind to the GST control but are pulled-down
with NR2E1-GST. Also note the absence of binding of PRGC1 to both
GST control and GST-NR2E1. GST input represents images of Ponceau
S-stained blots that were converted to black and white. b Immunopre-
cipitation was carried out using anti-P300, anti-EGPP, and anti-Myc
antibodies. Complexes were resolved by SDS-PAGE followed by western
blot. GST-NR2E1 was detected using anti-GST antibody. Note the binding
of GST-NR2E1 to P300 and AR but not to PRGC1. GST, glutathione-S-
transferase; IP, immunoprecipitation; WB, western blot
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Alternatively, since we only used the ligand binding
domain of NR2E1 in the array whereas our mouse
strains express the full length protein (wild-type or
variant), it is possible that the NR2E1-co-regulator
complexes are more stable in the full length conform-
ation. In this way, some co-regulators could bind to
NR2E1 through both its LBD and DBD as is the case for
LSD1 [15]. It is also possible that variant R274G could
have an effect on brain development. However, we could
not assess this phenotype as the BAC we use in this
study does not completely rescue the brain abnormalities
observed in Nr2e−/− [47].
The mouse model harboring the variant R274G
validates again the usefulness of our cloning strategy
showing that a single-copy human gene incorporated
into the Hprt locus is functional. This strategy could be
useful to study human mutations in the regulatory or
coding regions of disease-causing genes.
Similar to COUP-TFII, which can be activated by
retinoic acids despite its autorepressed conformation
[56], NR2E1 can be regulated by artificial ligands [57].
Therefore, a peptide array could represent a rapid
screening tool for small molecules that modify the ability
of NR2E1 to bind co-regulators.
Conclusion
By using a highly specific peptide array, we uncovered
novel putative interactors for NR2E1 including the
co-activator P300 and the nuclear receptor AR. Fu-
ture experiments will aim to validate the interactions
here discovered and understand their biological sig-
nificance. This array could be used to test small mol-
ecules and mutations that may alter the interaction of
NR2E1 with co-regulators and therefore its transcrip-
tional function.
Fig. 6 The variant R274G rescued retinal blood vessel numbers and thickness. P28 Nr2e1+/+ and Nr2e1frc/frc controls, and Nr2e1frc/frc mice harboring
a human NR2E1 or R274G BAC single-copy knock-in at the Hprt locus were studied. a Fundus pictures showing reduced blood vessel numbers
and abnormal morphology of Nr2e1frc/frc mice, similar to previous reports [10, 47], and apparent rescue of this defect by both NR2E1 and the
variant R274G. b Quantification of retinal blood vessels showing a reduction in Nr2e1frc/frc retinas compared to wild-type numbers. NR2E1 and the
variant R274G rescued this defect. c Paraffin-embedded eyes were sectioned at 5 μm thickness. Central sections containing the optic nerve were
stained with H and E. Representative retinal pictures are depicted showing very thin retinas in Nr2e1frc/frc mice and apparent rescue of this defect
by NR2E1 and the variant R274G. d Quantification of retinal thickness showed a high reduction in Nr2e1frc/frc retinas compared to wild-type and a
rescue of this defect by NR2E1 and the variant R274G. Error bars, standard error of the mean; GCL, ganglion cell layer; INL, inner nuclear layer; ns,
no significant; ON, optic nerve; ONL, outer nuclear layer; P#, postnatal day #; *, p < 0.001. n = 6 (12 eyes)
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Methods
Microarray assay for real-time analysis of co-regulator–nu-
clear receptor interaction (MARCoNI)
The peptide array assay was performed on Nuclear Re-
ceptor PamChip Arrays (PamGene International, B.V.,
Den Bosch, the Netherlands) harboring 154 immobilized
peptides corresponding to co-regulator-derived NR
interaction motifs (#88101; PamGene International[19])
as described before [58]. We added a peptide from Dros-
ophila atrophin-1, called the Atro box (PYADT-
PALRQLSEYARPHVAFS) as a positive control and a
mutant Atro box in which two leucines were substituted
with alanines (PYADTPAARQASEYARPHVAFS) as a
negative control [20]. Briefly, lysates were prepared from
HEK293 cells transfected with the human NR2E1 ligand
binding domain FLAG-tagged at the N-terminus
(FLAG-NR2E1LBD), wild-type or containing the variants
R274G or R276Q as described below. The concentration
of FLAG-NR2E1LBD in the lysates was assessed by west-
ern blot and the quantities of each sample were adjusted
such that equal amounts of NR2E1 proteins were added
to the array. Sample IDs were randomly assigned to
allow for a blinded experiment. Anti-FLAG M2 mono-
clonal antibody-FITC conjugate (Sigma-Aldrich, St.
Louis, MO, #F4049) at 1.1 mg/ml was added to the ly-
sates to detect the overexpressed proteins.
The arrays were incubated with 25 μL blocking buffer
(TBS with 1 % BSA, 0.01 %, Tween-20, and 0.3 %
skimmed milk) for 20 cycles. Subsequently, each array
was incubated with 7–10 μL of assay mix (TBS with
0.2 % BSA, 0.05 % Tween-20, 50 μM DTT, 2 % DMSO,
25 nM anti-Flag-FITC) for 120 cycles (30 s/cycle) and
washed with 25 μL TBS. After washing an additional
detection step was performed with 54 nM goat anti
mouse FITC (Santa Cruz #SC-2010, 200 μg/ml) for
20 cycles and washed with 25 μl TBS. At cycle 163, a
TIFF (Tagged Image File Format) image was captured by
the CCD camera. Image analysis was performed by auto-
mated spot finding and quantification using BioNaviga-
tor software (PamGene International BV) as described
before [58]. The background was discounted from the spot
signal. Each immobilized peptide was quantitatively assessed
for abundance, using Syproruby staining, and functionality,
using a standard glucocorticoid receptor MARCoNI assay,
which measures dexamethasone-induced modulation.
Three technical replicates were performed.
Plasmid constructs and site-directed mutagenesis
To make FLAG-NR2E1LBD, the NR2E1 ligand binding
domain (LBD) was cloned into the pEGFP-N1 vector
(Clontech, CA, USA) using EcoRI and NotI enzymes
(Invitrogen, CA, USA). The EGFP coding region was
replaced with NR2E1 LBD that was either wild-type or
that contained the R274G or R276Q amino-acid





TAC-3′. The forward primer also contained the FLAG-
tag coding sequence.
Site directed mutagenesis was performed with the
Quik-Change® Lightning Site-Directed Mutagenesis Kit
(Stratagene, CA, USA) on wild-type NR2E1 according to
manufacturer’s instructions. Primers used were forward
5′-GAGGTGGTGGCTCGATTTCAACAACTCCGGTT
AGATGC-3′ and reverse 5′-GCATCTAACCGGAGT
TGTTGAAATCGAGCCACCACCTC-3′ for R274G; and
forward 5′-GCTTTACAAGAGGTGGTGGCTGGATTTA-
GACAACTCC-3′ and reverse 5′-GGAGTTGTCTAAATC-
CAGCCACCACCACTTGTAAAGC-3′ for R276Q.
GST-NR2E1 was generated by cloning full-length
NR2E1 into pGEX-2 T vector (Clontech, CA, USA)
using BamHI and EcoRI enzymes (Invitrogen, CA,





pEGFP-C1-AR (Deposited by Michael Mancini [59],
Plasmid #28235), pCMVβ-p300-myc (Deposited by Tso-
Pang Yao, Plasmid #30489), and pcDNA4 myc-PGC-1
alpha (Deposited by Toren Finkel [60], Plasmid #10974)
were purchased from Addgene (Cambridge, MA, USA).
The GST human -Arophin-1846–1191 construct was
kindly donated by Dr. Chih-Cheng Tsai (Baylor College
of Medicine, Houston, TX, USA).
Protein expression and protein lysates preparation
One Shot® BL21 Star™ (DE3) Chemically Competent E.
coli (Life Technologies, Carlsbad, CA, USA) were trans-
formed with GST-atrophin-1 or GST-NR2E1 constructs.
Subsequently, a bacterial colony was grown in 10 mL of
LB media containing 100 μg/mL Ampicillin overnight.
Five μL of the overnight culture were added to 100 mL
of LB (1:50 dilution) containing 100 μg/mL Ampicillin
and grown to reach an OD600 of 0.5 (mid-log). Bacteria
were induced with 0.1 mM IPTG for 4 h at 37 °C.
Bacteria were pelleted at 7,000x g for 7 min, washed with
STE buffer (10 mM Tris pH8.0, 150 mM NaCl and
1 mM EDTA) and resuspended in STE buffer containing
protease inhibitors (Roche, Roche, Basel, Switzerland)
and 100 μg/mL of lysozyme. Cells were incubated
15 min on ice and DTT was added to a final concentra-
tion of 5 mM. Subsequently, Sarkosyl was added to a
final concentration of 0.2 %, and lysates were vortexed
and sonicated on iced twice for 15 s each. Lysates were
adjusted to 1 % Triton X-100 and centrifuged at 20,000x
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g for 15 min at 4 °C. Supernatants were collected and
used in subsequent experiments.
To express FLAG-NR2E1LBD variants, HEK293 cells
were grown in T-75 flasks and transfected with each of
the different constructs. Forty-eight hours after transfec-
tion, cells were washed with PBS and lysed in ice-cold
solubilization buffer [20 mM Tris HCl, pH8.0, 1 %
NP40, 10 % glycerol, and 137 mM NaCl] with protease
inhibitor cocktail (Roche, Basel, Switzerland) and
1 mM phenylmethylsulfonyl fluoride (PMSF). Cells
were sonicated for 10 s and centrifuged at 20,000x g
for 10 min at 4 °C.
Pull-down experiments
Bacterial lysates were incubated with glutathione
MagBeads (GenScript, Piscataway, NJ, USA) for one
hour. Beads were then washed twice with PBS and incu-
bated in 1 % BSA/PBS for one additional hour. HEK293
lysates were adjusted to 0.1 % BSA and incubated with
the beads for two hours at 4 °C. Beads were washed
three times for 30 min before adding 50 μL of loading
buffer. SDS-Polyacrylamide gel electrophoresis was per-
formed with the final sample from the beads and 3 % of
recovered input. For immunoprecipitation experiments,
HEK293 lysates were precleared with protein A beads
for 1 h and added to beads-antibody conjugates for an
additional hour. After removing the supernatant, the
second HEK293 lysate expressing the candidate interac-
tor was added for 2 h. Beads were washed four times
with solubilization buffer before proceeding to SDS-
PAGE. Antibodies used were rabbit anti-P300 (Sydlabs,
Natick, MA, USA), rabbit anti-EGFP (Invitrogen,
Carlsbad, CA, USA), rabbit anti-Myc and rabbit anti-
Flag (Sigma-Aldrich, St. Louis, MO, USA).
Western blot
Samples containing 1X loading buffer were incubated at
75 °C for 10 min and loaded into NuPAGE® Novex
Bis-Tris Gels (Invitrogen, Carlsbad, CA, USA). Gels were
run for 30–45 min at 150 V. Subsequently transfer onto
polyvinylidene difluoride (PVDF) membranes was per-
formed for 90 min at 30 V. After transfer, membranes
were washed and incubated in blocking solution (5 %
milk in Tween-20-TBS) for one hour. Subsequently,
membranes were incubated with primary antibodies in
blocking solution overnight at 4 °C. Antibodies used
were rabbit anti-P300 (Sydlabs, Natick, MA, USA),
rabbit anti-EGFP (Invitrogen, Carlsbad, CA, USA), rat
anti-GST, rabbit anti-Myc, and rabbit anti-Flag (Sigma-
Aldrich, St. Louis, MO, USA). After three washes of
10 min each, membranes were incubated with
peroxidase-conjugated secondary antibodies. After three
subsequent washes, the membrane was incubated with
Pierce™ ECL Chemiluminescent Substrate (Thermo
Fisher Scientific Inc, Rockville, MD, USA) and exposed
to Fuji Rx film.
Mouse strains husbandry and breeding
B6.129P2(Cg)-Hprttm330(NR2E1,bEMS112)Ems mice were gen-
erated from embryonic stem cells (ESCs) (clone
mEMS4738) that harbored the bacterial artificial
chromosome (BAC) bEMS112 (containing variant
R274G) knock-in allele at the mouse Hprt locus, as
previously described [47, 48]. Only male mice were
studied to avoid variability due to random X inactivation
of the knock-in allele at Hprt. Experimental animals for
studying NR2E1 BAC bEMS112 were generated through
a breeding strategy described before [47]. Briefly, B6
(C57BL/6 J) females heterozygous for the BAC insert
(N > 10) and for the fierce deletion (B6.Cg-
Hprttm85(NR2E1,bEMS112)Ems/X, Nr2e1frc/+) were crossed to
129 (129S1/SvImJ) males heterozygous for the fierce
mutation (129S1/SvImJ.Cg-Nr2e1frc/+) (N > 10). This
produced first-generation hybrid offspring (B6129F1),
abbreviated here as Nr2e1+/+; Nr2e1frc/+; Nr2e1frc/frc;
Nr2e1+/+, NR2E1; Nr2e1frc/+, NR2E1; Nr2e1frc/frc, NR2E1;
Nr2e1+/+, R274G; Nr2e1frc/+, R274G; and Nr2e1frc/frc,
R274G. Mice were kept in a pathogen-free animal facility
at the Centre for Molecular Medicine and Therapeutics
(Vancouver, BC, Canada) on an 6 am to 8 pm light cycle
at 20 ± 2 °C with 50 % ± 5 % relative humidity, and food
and water ad libitum.
Funduscopy
To assess the number of retinal blood vessels, fundus-
copy was performed using a Kowa Genesis small animal
fundus camera (Pacific Medical, Delta, BC, Canada) as
previously described [47, 61]. In short, eyes were dilated
with 1 % atropine/PBS and photographed after 30 min.
Animals were manually restrained without sedation.
Histology
Eyes were dissected, washed once in PBS and incubated
overnight in Davidson’s fixative. Eyes were stored in
70 % ethanol until paraffin embedment. Eyes were sec-
tioned at 5 μm and mounted on SuperFrost Plus slides.
To evaluate retinal thickness, eyes were subjected to
hematoxylin and eosin staining. Briefly, tissue was incu-
bated in hematoxylin for 5 min, washed in tap water and
incubated in 1 % lithium carbonate solution for 30 s.
After washing in tap water again, the tissue was incu-
bated in acid alcohol (1 %) for 5 s followed by another
tap water wash and incubation in eosin Y solution for
5 min. After a final tap water wash, tissue was dehy-
drated in a gradient series of ethanol and xylene before
mounting for microscopy. Retinal sections were chosen
such that they contained the optic nerve and retinal
thickness was measured 600 μm away from the optic
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nerve using the software ImageJ [62]. One section per
eye and two eyes per animal were studied. Retinal sec-
tions were imaged with the Olympus BX61 motorized
microscope using the software DP Controller (Olympus,
Tokyo, Japan).
Statistical analysis
Statistical analysis was performed using the software
XLSTAT. T-test was used to calculate differences be-
tween groups. False discovery rate (FDR) q-values were
calculated using the Benjamini-Hochberg procedure to
correct for multiple hypothesis testing [63]. A compari-
son between signal intensities in the western blot was
performed by one-way ANOVA.
Additional files
Additional file 1: Table S1. List of all peptides used in the MARCoNI
array and their corresponding binding values to NR2E1 Wt and variants
R274G and R276Q. (XLS 48 kb)
Additional file 2: Table S2. Densitometry analysis of western blot
signal after pulling-down NR2E1 Wt and variants with GST-Atrophin-1.
(XLSX 9 kb)
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